Absolute quantitation of low abundance plasma APL1β peptides at Sub-fmol/mL level by SRM/MRM without immunoaffinity enrichment

Journal of Proteome Research

Volumn 13, Issue 2, 2014, Pages 1012-1020

  Sano, Shozo ^a   Tagami, Shinji ^b   Hashimoto, Yuuki ^a   Yoshizawa Kumagaye, Kumiko ^c   Tsunemi, Masahiko ^c   Okochi, Masayasu ^b   Tomonaga, Takeshi ^a  

^a NATIONAL INSTITUTE OF BIOMEDICAL INNOVATION   (Japan)

^b OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c Peptide Institute Inc   (Japan)

Author keywords

Alzheimer's disease; low abundant plasma peptide; peptide enrichment; SRM MRM

Indexed keywords

AMINO ACID SEQUENCE; CHAPERONIN 60; CHROMATOGRAPHY, AFFINITY; ELECTROPHORESIS, POLYACRYLAMIDE GEL; HUMANS; LIMIT OF DETECTION; MOLECULAR SEQUENCE DATA; PEPTIDE FRAGMENTS; REFERENCE STANDARDS;

EID: 84893827384     PISSN: 15353893     EISSN: 15353907     Source Type: Journal    
DOI: 10.1021/pr4010103     Document Type: Article

References (32)

1. Lange, V.; Picotti, P.; Domon, B.; Aebersold, R. Selected reaction monitoring for quantitative proteomics: a tutorial Mol. Syst. Biol. 2008, 4, 222
2. Kuhn, E.; Wu, J.; Karl, J.; Liao, H.; Zolg, W.; Guild, B. Quantification of C-reactive protein in the serum of patients with rheumatoid arthritis using multiple reaction monitoring mass spectrometry and 13C-labeled peptide standards Proteomics 2004, 4 (4) 1175-86
3. Anderson, L.; Hunter, C. L. Quantitative mass spectrometric multiple reaction monitoring assays for major plasma proteins Mol. Cell. Proteomics 2006, 5 (4) 573-88
4. Keshishian, H.; Addona, T.; Burgess, M.; Kuhn, E.; Carr, S. A. Quantitative, multiplexed assays for low abundance proteins in plasma by targeted mass spectrometry and stable isotope dilution Mol. Cell. Proteomics 2007, 6 (12) 2212-29
5. Keshishian, H.; Addona, T.; Burgess, M.; Mani, D. R.; Shi, X.; Kuhn, E.; Sabatine, M. S.; Gerszten, R. E.; Carr, S. A. Quantification of cardiovascular biomarkers in patient plasma by targeted mass spectrometry and stable isotope dilution Mol. Cell. Proteomics 2009, 8 (10) 2339-49
6. Liu, T.; Qian, W. J.; Mottaz, H. M.; Gritsenko, M. A.; Norbeck, A. D.; Moore, R. J.; Purvine, S. O.; Camp, D. G., 2nd; Smith, R. D. Evaluation of multiprotein immunoaffinity subtraction for plasma proteomics and candidate biomarker discovery using mass spectrometry Mol. Cell. Proteomics 2006, 5 (11) 2167-74
7. Qian, W. J.; Kaleta, D. T.; Petritis, B. O.; Jiang, H.; Liu, T.; Zhang, X.; Mottaz, H. M.; Varnum, S. M.; Camp, D. G., 2nd; Huang, L.; Fang, X.; Zhang, W. W.; Smith, R. D. Enhanced detection of low abundance human plasma proteins using a tandem IgY12-SuperMix immunoaffinity separation strategy Mol. Cell. Proteomics 2008, 7 (10) 1963-73
8. Anderson, N. L.; Anderson, N. G.; Haines, L. R.; Hardie, D. B.; Olafson, R. W.; Pearson, T. W. Mass spectrometric quantitation of peptides and proteins using Stable Isotope Standards and Capture by Anti-Peptide Antibodies (SISCAPA) J. Proteome Res. 2004, 3 (2) 235-44
9. Whiteaker, J. R.; Zhao, L.; Zhang, H. Y.; Feng, L. C.; Piening, B. D.; Anderson, L.; Paulovich, A. G. Antibody-based enrichment of peptides on magnetic beads for mass-spectrometry-based quantification of serum biomarkers Anal. Biochem. 2007, 362 (1) 44-54
10. Kuhn, E.; Addona, T.; Keshishian, H.; Burgess, M.; Mani, D. R.; Lee, R. T.; Sabatine, M. S.; Gerszten, R. E.; Carr, S. A. Developing multiplexed assays for troponin I and interleukin-33 in plasma by peptide immunoaffinity enrichment and targeted mass spectrometry Clin. Chem. 2009, 55 (6) 1108-17
11. Whiteaker, J. R.; Zhao, L.; Anderson, L.; Paulovich, A. G. An automated and multiplexed method for high throughput peptide immunoaffinity enrichment and multiple reaction monitoring mass spectrometry-based quantification of protein biomarkers Mol. Cell. Proteomics 2010, 9 (1) 184-96
12. Whiteaker, J. R.; Zhao, L.; Abbatiello, S. E.; Burgess, M.; Kuhn, E.; Lin, C.; Pope, M. E.; Razavi, M.; Anderson, N. L.; Pearson, T. W.; Carr, S. A.; Paulovich, A. G. Evaluation of large scale quantitative proteomic assay development using peptide affinity-based mass spectrometry Mol. Cell. Proteomics 2011, M110.005645
13. Lopez, M. F.; Rezai, T.; Sarracino, D. A.; Prakash, A.; Krastins, B.; Athanas, M.; Singh, R. J.; Barnidge, D. R.; Oran, P.; Borges, C.; Nelson, R. W. Selected reaction monitoring-mass spectrometric immunoassay responsive to parathyroid hormone and related variants Clin. Chem. 2010, 56 (2) 281-90
14. Shi, T.; Fillmore, T. L.; Sun, X.; Zhao, R.; Schepmoes, A. A.; Hossain, M.; Xie, F.; Wu, S.; Kim, J. S.; Jones, N.; Moore, R. J.; Pasa-Tolic, L.; Kagan, J.; Rodland, K. D.; Liu, T.; Tang, K.; Camp, D. G., 2nd; Smith, R. D.; Qian, W. J. Antibody-free, targeted mass-spectrometric approach for quantification of proteins at low picogram per milliliter levels in human plasma/serum Proc. Natl. Acad. Sci. U.S.A. 2012, 109 (38) 15395-400
15. Masters, C. L.; Simms, G.; Weinman, N. A.; Multhaup, G.; McDonald, B. L.; Beyreuther, K. Amyloid plaque core protein in Alzheimer disease and Down syndrome Proc. Natl. Acad. Sci. U.S.A. 1985, 82 (12) 4245-9
16. Selkoe, D. J. Alzheimer's disease: genes, proteins, and therapy Physiol. Rev. 2001, 81 (2) 741-66
17. Andreasen, N.; Hesse, C.; Davidsson, P.; Minthon, L.; Wallin, A.; Winblad, B.; Vanderstichele, H.; Vanmechelen, E.; Blennow, K. Cerebrospinal fluid beta-amyloid(1-42) in Alzheimer disease: differences between early- and late-onset Alzheimer disease and stability during the course of disease Arch. Neurol. 1999, 56 (6) 673-80
18. Jensen, M.; Schroder, J.; Blomberg, M.; Engvall, B.; Pantel, J.; Ida, N.; Basun, H.; Wahlund, L. O.; Werle, E.; Jauss, M.; Beyreuther, K.; Lannfelt, L.; Hartmann, T. Cerebrospinal fluid A beta42 is increased early in sporadic Alzheimer's disease and declines with disease progression Ann. Neurol. 1999, 45 (4) 504-11
19. Motter, R.; Vigo-Pelfrey, C.; Kholodenko, D.; Barbour, R.; Johnson-Wood, K.; Galasko, D.; Chang, L.; Miller, B.; Clark, C.; Green, R. Reduction of beta-amyloid peptide42 in the cerebrospinal fluid of patients with Alzheimer's disease Ann. Neurol. 1995, 38 (4) 643-8
20. Okochi, M.; Steiner, H.; Fukumori, A.; Tanii, H.; Tomita, T.; Tanaka, T.; Iwatsubo, T.; Kudo, T.; Takeda, M.; Haass, C. Presenilins mediate a dual intramembranous gamma-secretase cleavage of Notch-1 EMBO J. 2002, 21 (20) 5408-16
21. Yanagida, K.; Okochi, M.; Tagami, S.; Nakayama, T.; Kodama, T. S.; Nishitomi, K.; Jiang, J.; Mori, K.; Tatsumi, S.; Arai, T.; Ikeuchi, T.; Kasuga, K.; Tokuda, T.; Kondo, M.; Ikeda, M.; Deguchi, K.; Kazui, H.; Tanaka, T.; Morihara, T.; Hashimoto, R.; Kudo, T.; Steiner, H.; Haass, C.; Tsuchiya, K.; Akiyama, H.; Kuwano, R.; Takeda, M. The 28-amino acid form of an APLP1-derived Abeta-like peptide is a surrogate marker for Abeta42 production in the central nervous system EMBO Mol. Med. 2009, 1 (4) 223-35
22. Zheng, X.; Baker, H.; Hancock, W. S. Analysis of the low molecular weight serum peptidome using ultrafiltration and a hybrid ion trap-Fourier transform mass spectrometer J. Chromatogr. A 2006, 1120 (1-2) 173-84
23. Tammen, H.; Schulte, I.; Hess, R.; Menzel, C.; Kellmann, M.; Mohring, T.; Schulz-Knappe, P. Peptidomic analysis of human blood specimens: comparison between plasma specimens and serum by differential peptide display Proteomics 2005, 5 (13) 3414-22
24. Kay, R.; Barton, C.; Ratcliffe, L.; Matharoo-Ball, B.; Brown, P.; Roberts, J.; Teale, P.; Creaser, C. Enrichment of low molecular weight serum proteins using acetonitrile precipitation for mass spectrometry based proteomic analysis Rapid Commun. Mass Spectrom. 2008, 22 (20) 3255-60
25. Aristoteli, L. P.; Molloy, M. P.; Baker, M. S. Evaluation of endogenous plasma peptide extraction methods for mass spectrometric biomarker discovery J. Proteome Res. 2007, 6 (2) 571-81
26. Chambers, E. E.; Lame, M. E.; Bardsley, J.; Hannam, S.; Legido-Quigley, C.; Smith, N.; Fountain, K. J.; Collins, E.; Thomas, E. High sensitivity LC-MS/MS method for direct quantification of human parathyroid 1-34 (teriparatide) in human plasma J. Chromatogr. B: Anal. Technol. Biomed. Life Sci. 2013, 938, 96-104
27. Chen, Z.; Caulfield, M. P.; McPhaul, M. J.; Reitz, R. E.; Taylor, S. W.; Clarke, N. J. Quantitative insulin analysis using liquid chromatography-tandem mass spectrometry in a high-throughput clinical laboratory Clin. Chem. 2013, 59 (9) 1349-56
28. Miyachi, A.; Murase, T.; Yamada, Y.; Osonoi, T.; Harada, K. Quantitative analytical method for determining the levels of gastric inhibitory polypeptides GIP1-42 and GIP3-42 in human plasma using LC-MS/MS/MS J. Proteome Res. 2013, 12 (6) 2690-9
29. Rappsilber, J.; Mann, M.; Ishihama, Y. Protocol for micro-purification, enrichment, pre-fractionation and storage of peptides for proteomics using StageTips Nat. Protoc. 2007, 2 (8) 1896-906
30. Muraoka, S.; Kume, H.; Watanabe, S.; Adachi, J.; Kuwano, M.; Sato, M.; Kawasaki, N.; Kodera, Y.; Ishitobi, M.; Inaji, H.; Miyamoto, Y.; Kato, K.; Tomonaga, T. Strategy for SRM-based verification of biomarker candidates discovered by iTRAQ method in limited breast cancer tissue samples J. Proteome Res. 2012, 11 (8) 4201-10
31. Whiteaker, J. R.; Lin, C.; Kennedy, J.; Hou, L.; Trute, M.; Sokal, I.; Yan, P.; Schoenherr, R. M.; Zhao, L.; Voytovich, U. J.; Kelly-Spratt, K. S.; Krasnoselsky, A.; Gafken, P. R.; Hogan, J. M.; Jones, L. A.; Wang, P.; Amon, L.; Chodosh, L. A.; Nelson, P. S.; McIntosh, M. W.; Kemp, C. J.; Paulovich, A. G. A targeted proteomics-based pipeline for verification of biomarkers in plasma Nat. Biotechnol. 2011, 29 (7) 625-34
32. Schoenherr, R. M.; Whiteaker, J. R.; Zhao, L.; Ivey, R. G.; Trute, M.; Kennedy, J.; Voytovich, U. J.; Yan, P.; Lin, C.; Paulovich, A. G. Multiplexed quantification of estrogen receptor and HER2/Neu in tissue and cell lysates by peptide immunoaffinity enrichment mass spectrometry Proteomics 2012, 12 (8) 1253-60